Abstract
Abstract
Introduction
Following the COVID-19 directive to cease non-essential services, a rapid shift was made in the delivery of Speech Language Pathology (SLP) dysphagia management in the 3-arm, randomized PRO-ACTIVE trial. To inform future programs, this study explored patients’ experiences with telehealth when the planned in-person SLP intervention was moved to a telehealth modality.
Methods
A theory-guided qualitative descriptive approach was used. Willing participants who had received at least one telehealth swallowing therapy session participated in a one-time semi-structured interview. Interview transcripts were subjected to a standard qualitative content/theme analysis. Researchers reviewed all transcripts and used a multi-step analysis process to build a coding framework through consensus discussion. Summaries and key messages were generated for each code.
Results
Eleven participants recounted their telehealth experiences and reported feeling satisfied, comfortable and confident with the session(s). They identified that previous experience with teleconferencing, access to optimal technical equipment, clinician skill, and caregiver assistance facilitated their telehealth participation. Participants highlighted that telehealth was beneficial as it reduced commuting time, COVID-19 exposure and fatigue from travel; and also allowed caregiver participation particularly during COVID. In comparing their in-person SLP sessions to telehealth sessions, limitations were also identified, including: lack of previous experience with and/or poor access to technology, and less opportunity for personalization. Participants indicated that use of phone alone was less preferred than an audio/video platform.
Discussion
Patients reported that overall, telehealth sessions did not compromise their learning experience when compared to in-person sessions. Patients benefited from use of telehealth in several ways despite some limitations of the use of technology. Patient feedback about telehealth provides an important perspective that may be critical to inform best practices for care delivery.
Publisher
Springer Science and Business Media LLC
Reference37 articles.
1. Gascon L, Fournier I, Chiesa-Estomba C, Russo G, Fakhry N, Lechien JR, et al. Systematic review of international guidelines for head and neck oncology management in COVID-19 patients. Eur Arch Otorhinolaryngol. 2021;23:1–37.
2. Givi B, Schiff BA, Chinn SB, Clayburgh D, Iyer NG, Jalisi S, et al. Safety recommendations for evaluation and surgery of the head and neck during the COVID-19 pandemic. JAMA Otolaryngol Head Neck Surg. 2020;146(6):579–84.
3. Ku PKM, Holsinger FC, Chan JYK, Yeung ZWC, Chan BYT, Tong MCF, et al. Management of dysphagia in the patient with head and neck cancer during COVID-19 pandemic: practical strategy. Head Neck. 2020;42(7):1491–6.
4. Malandraki GA, Arkenberg RH, Mitchell SS, Malandraki JB. Telehealth for dysphagia across the life span: using contemporary evidence and expertise to guide clinical practice during and after COVID-19. Am J Speech Lang Pathol. 2021;30(2):532–50.
5. Miles A, Connor NP, Desai RV, Jadcherla S, Allen J, Brodsky M, et al. Dysphagia care across the continuum: a multidisciplinary dysphagia research society taskforce report of service-delivery during the COVID-19 global pandemic. Dysphagia. 2021;36(2):170–82.
Cited by
8 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献